Navigation Links
Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer
Date:9/12/2011

AUSTIN, Texas, Sept. 12, 2011 /PRNewswire/ -- Hanger Orthopedic Group, Inc. today announced the appointment of Vinit K. Asar to President and Chief Operating Officer, effective immediately.  Mr. Asar joined the company in December 2008 as Executive Vice President and Chief Growth Officer with nearly 20 years of global business operations experience in the medical device sector at Johnson & Johnson.  In his new position, Mr. Asar will continue to lead Hanger's emerging businesses and growth opportunities, while taking on additional responsibility for Hanger's SPS and Linkia business units in distribution and network management, respectively.  

"Vinit has brought a new level of enterprise strategic thinking to Hanger," Hanger Orthopedic Group Chief Executive Officer Thomas F. Kirk said.  "His invaluable contributions have led to calculated growth, disciplined operational diversification, and advancement of our vision.  We are confident this same commitment and foresight will translate to new success in the management of his new responsibilities. "

Over the past two years, Mr. Asar led the identification, development, and execution of new opportunities for Hanger's existing operations and launched new business initiatives consistent with the company's overall growth strategy.  Mr. Asar played a primary role (ultimately assuming subsequent management of the business unit) in Hanger's $155 million acquisition of Accelerated Care Plus (ACP), the nation's leading provider of integrated clinical programs for sub-acute and long-term care rehabilitation providers.  

"I am continually inspired by Hanger's outstanding talent, commitment to its patients and customers, and innovative products and services," Mr. Asar said.  "With a strong foundation built on 150 years of clinical excellence, I am very optimistic about our future prospects and growth potential.  I am delighted to serve in this leadership position."

About Hanger – Hanger Orthopedic Group, Inc. (NYSE: HGR), headquartered in Austin, Texas, is the world's premier provider of services and products that enhance human physical capability. Hanger provides orthotic and prosthetic patient care services, distributes O&P devices and components and provides therapeutic solutions to the broader post-acute market. Hanger is the largest owner and operator of orthotic and prosthetic patient care centers, with in excess of 675 O&P patient care centers located in 45 states and the District of Columbia. Hanger, through its subsidiary Southern Prosthetic Supply, is also the largest distributor of branded and private label O&P devices and components in the United States. Hanger provides therapeutic solutions through its subsidiaries Innovative Neurotronics and Accelerated Care Plus. Innovative Neurotronics introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. Accelerated Care Plus is a developer of specialized rehabilitation technologies and the nation's leading provider of evidence-based clinical programs for post-acute rehabilitation, serving more than 4,000 long-term care facilities and other sub-acute rehabilitation providers throughout the U.S. For more information on Hanger, visit www.hanger.com.

This document contains forward-looking statements relating to the Company's results of operations. The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements. Statements relating to future results of operations in this document reflect the current views of management. However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Hanger Orthopedic Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hanger Orthopedic Group Announces Five Acquisitions Producing $20.2 million of Annual Net Revenue
2. Hanger Orthopedic Group Celebrates Its 150th Anniversary: Celebrations to Commence with NYSE Bell Ringing on August 10
3. Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medcos Advanced Oncology Solutions™
4. Hanger Orthopedic Group, Inc. Announces Second Quarter 2011 Earnings Release Conference Call
5. Hanger Orthopedic Group Reports First Quarter Results
6. Hanger Orthopedic Group, Inc. Announces First Quarter 2011 Earnings Release Conference Call
7. Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2010 Earnings Release Conference Call
8. Hanger Orthopedic Group, Inc. Completes Exchange Offer of 7 1/8% Senior Notes Due 2018
9. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
10. Hanger Orthopedic Group, Inc. Announces Expiration of Offer to Purchase Outstanding 10 1/4% Senior Notes Due 2014
11. Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ( ... to drug research and development, today announced the ... QSP Day 2017 is a day full of ... systems pharmacology (QSP) community. The focus is to ... de-risking and accelerating drug research and development. ...
(Date:3/22/2017)... MARLBOROUGH, Mass. , March 22, 2017 ... that it has completed the acquisition of Cynosure, Inc., ... $66 per share in cash. "We are ... forward to working with Michael Davin and ... in the large, rapidly growing medical aesthetics market," said ...
(Date:3/22/2017)... FinancialBuzz.com News Commentary ... to the significant development and innovation in EP technologies. ... the global electrophysiology market was worth $3.42 billion in ... 2022, with a GAGR of 13.4%. Electrophysiology is a ... heartbeats or arrhythmia. The report indicates that in addition ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic ... extensive therapeutic experience and operational excellence in oncology clinical trials, proudly announces today ... the treatment of non-small cell lung cancer and small cell lung cancer. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a Long ... Nassau County region, is embarking on a combined charity effort with the Great Neck ... the last 25 years, the Great Neck Breast Cancer Coalition has worked to support ...
(Date:3/22/2017)... ... March 22, 2017 , ... Schneider Insurance and Financial, a southern Montana firm ... Yellowstone Valley region, is launching a charity event aimed at raising local support for ... of Montana State, and is home to a broad variety of animals from all ...
(Date:3/22/2017)... ... 22, 2017 , ... Martin J. Mitchell Insurance, a Columbus ... throughout central Ohio, is initiating a charity drive to raise support for nearby ... and the Veteran's Brain Injury Center conclude that more than one in five ...
(Date:3/22/2017)... ... March 22, 2017 , ... HumanHaus is proud to ... The conventional broom was great when it was invented, but our customers today ... working parents, the social young couple, the empty nesters and retired that want to ...
Breaking Medicine News(10 mins):